Chronic Disease Control

Construction of a risk prediction model for type 2 diabetic kidney disease based on the inflammatory indices SII and SIRI

  • Yongsi LIU ,
  • Yingmin DENG ,
  • Marsu VANAKHUN ,
  • Ruijing LI ,
  • Wen SHI ,
  • Chuyun CHEN
Expand
  • 1.The Affiliated Guangzhou Hospital of TCM of Guangzhou University of Chinese Medicine,Guangzhou 510130,Guangdong,China
    2.Guangzhou University of Chinese Medicine International College,Guangzhou 510006,Guangdong,China
    3.Department of Acupuncture,the Affiliated Traditional Chinese Medicine Hospital,Guangzhou Medical University Guangzhou Guangdong,510130,China

Received date: 2025-09-25

  Revised date: 2025-11-09

  Accepted date: 2025-11-17

  Online published: 2026-01-22

Abstract

Objective To construct an optimal risk prediction model for diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM) based on routine blood indicators combined with the systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI), and to compare the predictive performance of different machine learning models, so as to provide an effective tool for the early screening of DKD. Methods A total of 658 T2DM patients hospitalized in the Affiliated Hospital of Traditional Chinese Medicine of Guangzhou Medical University from January 2023 to November 2024 were retrospectively selected as the research subjects. The patient data were divided into a training set (460 cases) and a test set (198 cases) at a ratio of 7∶3 using the computer simple random sampling method. First, LASSO regression was used to screen 12 potential predictive features including SII and SIRI. Then, based on the screened variables, four machine learning algorithms, namely logistic regression (LR), support vector machine (SVM), random forest (RF), and extreme gradient boosting (XGBoost), were applied to construct risk prediction models for DKD in T2DM patients. Indicators such as AUC value, sensitivity, accuracy, and F1 score were used to comprehensively evaluate the discrimination of the models, and the calibration curve and decision curve analysis (DCA) were used to evaluate the calibration and clinical utility of the models respectively. Finally, the SHAP method was used to conduct interpretability analysis of the optimal model. Results Ten predictive features were screened out by LASSO regression. SHAP values showed that creatinine had high importance in all four risk prediction models. The AUC values of the LR, RF, SVM, and XGBoost models in the test set were 0.914, 0.943, 0.929, and 0.917 respectively, and the F1 scores were 0.627, 0.737, 0.474, and 0.772 respectively. The overall accuracies obtained from the confusion matrix heat maps were 90.4%, 92.4%, 89.9%, and 93.4% respectively. The prediction accuracies of RF and XGBoost for DKD occurrence in the confusion matrix heat maps were relatively high, at 72.4% and 75.9% respectively. DCA showed that all four models had positive clinical net benefits at most threshold probabilities. Conclusion The RF and XGBoost models can accurately predict the risk of DKD in T2DM patients, which is helpful for clinicians to identify high-risk T2DM patients with DKD at an early stage.

Cite this article

Yongsi LIU , Yingmin DENG , Marsu VANAKHUN , Ruijing LI , Wen SHI , Chuyun CHEN . Construction of a risk prediction model for type 2 diabetic kidney disease based on the inflammatory indices SII and SIRI[J]. The Journal of Practical Medicine, 2026 , 42(2) : 266 -275 . DOI: 10.3969/j.issn.1006-5725.2026.02.012

References

[1] International Diabetes Federation.IDF Diabetes Atlas 2025[EB/OL]. (2025-10-10)[2025-10-28].
[2] 中华医学会糖尿病学分会. 中国糖尿病防治指南(2024版)[J]. 中华糖尿病杂志,2025,17(1):16-139. doi:10.3760/cma.j.cn115791-20241203-00705 .
[3] ELENDU C, JOHN OKAH M, FIEMOTONGHA K D J, et al. Comprehensive advancements in the prevention and treatment of diabetic nephropathy: A narrative review[J]. Medicine, 2023, 102(40): e35397. doi:10.1097/MD.0000000000035397 .
[4] 《糖尿病肾脏病早期筛查与管理专家共识》编写组. 糖尿病肾脏病早期筛查与管理专家共识(2025版)[J]. 中华糖尿病杂志, 2025, 17(7): 786-800. doi:10.3760/cma.j.cn115791-20241231-00768 .
[5] ZHOU Y, ZHANG Y, CHEN J, et al. Diagnostic value of α1-MG and URBP in early diabetic renal impairment[J]. Front Physiol, 2023, 14: 1173982. doi:10.3389/fphys.2023.1173982 .
[6] LI X, WANG L, LIU M, et al. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: A cross-sectional study[J]. Front Endocrinol, 2024, 14: 1285509. doi:10.3389/fendo.2023.1285509 .
[7] MORO-VALDEZATE D, MARTíN-ARéVALO J, CóZAR-LOZANO C, et al. Prognostic value of routine blood biomarkers in 3-year survival of resectable colorectal cancer patients: A prognostic nomogram for clinical practice[J]. Int J Colorectal Dis, 2025, 40(1): 58. doi:10.1007/s00384-025-04848-3 .
[8] 万梦园, 刘书娟, 刘晶晶, 等. 术前系统免疫炎症指数与胰腺癌患者预后的关系[J]. 实用医学杂志, 2021, 37(19): 2482-2486.doi:10.3969/j.issn.1006-5725.2021.19.010 .
[9] 朱吉玥, 张波, 李亚茹, 等. 全身炎症反应指数对早期结直肠癌内镜黏膜下剥离术后非治愈性切除的预测价值[J]. 实用医学杂志, 2025, 41(5): 716-723. doi:10.3969/j.issn.1006-5725.2025.05.015 .
[10] XIA Y, XIA C, WU L, et al. Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: A 20-year follow-up cohort study of 42, 875 US adults[J]. J Clin Med, 2023, 12(3): 1128. doi:10.3390/jcm12031128 .
[11] ?INARO?LU O S, ACAR H, ?AMYAR H, et al. The success of SII, MII-1, MII-2, MII-3, and QT dispersion in predicting the walled-off pancreatic necrosis development in acute pancreatitis in the emergency department: An observational study[J]. Medicine, 2024, 103(25): e38599. doi:10.1097/MD.0000000000038599 .
[12] LI X, CUI L, XU H. Association between systemic inflammation response index and chronic kidney disease: A population-based study[J]. Front Endocrinol, 2024, 15: 1329256. doi:10.3389/fendo.2024.1329256 .
[13] SONG Y, ZHAO Y, SHU Y, et al. Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: A cross-sectional study[J]. Front Endocrinol, 2023, 14: 1100453. doi:10.3389/fendo. 2023. 1100453 .
[14] SABERI-KARIMIAN M, KHORASANCHI Z, GHAZIZADEH H, et al. Potential value and impact of data mining and machine learning in clinical diagnostics[J]. Crit Rev Clin Lab Sci, 2021, 58(4): 275-296. doi:10.1080/10408363.2020.1857681 .
[15] ZOU Y, ZHAO L, ZHANG J, et al. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease[J]. Ren Fail, 2022, 44(1): 562-570. doi:10.1080/0886022X.2022.2056053 .
[16] ZOU L X, WANG X, HOU Z L, et al. Machine learning algorithms for diabetic kidney disease risk predictive model of Chinese patients with type 2 diabetes mellitus[J]. Ren Fail, 2025, 47(1): 2486558. doi:10.1080/0886022X.2025.2486558 .
[17] ZHOU Y C, LIU J M, ZHAO Z P, et al. The national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050[J]. Mil Med Res, 2025, 12(1): 28. doi:10.1186/s40779-025-00615-1 .
[18] WANG L, PENG W, ZHAO Z, et al. Prevalence and Treatment of Diabetes in China, 2013-2018[J]. JAMA, 2021, 326(24):2498-2506. doi:10.1001/jama.2021.22208. doi:10.3760/cma.j.issn.1674-5809.2019.05.003 .
[19] AFKARIAN M, SACHS M C, KESTENBAUM B, et al. Kidney disease and increased mortality risk in type 2 diabetes[J]. J Am Soc Nephrol, 2013, 24(2): 302-308. doi:10.1681/ASN. 2012070718 .
[20] BONNER R, ALBAJRAMI O, HUDSPETH J, et al. Diabetic kidney disease[J]. Prim Care Clin Off Pract, 2020, 47(4): 645-659. doi:10.1016/j.pop.2020.08.004 .
[21] 龚伟, 何敏, 俞一飞, 等. 住院2型糖尿病合并正常白蛋白尿的慢性肾脏病患者临床特征及危险因素分析[J]. 中华糖尿病杂志, 2018, 10(4): 269-273. doi:10.3760/cma.j.issn.1674-5809.2018.04.007 .
[22] NAGENDRAN M, CHEN Y, LOVEJOY C A, et al. Artificial intelligence versus clinicians: Systematic review of design, reporting standards, and claims of deep learning studies[J]. BMJ, 2020, 368: m689. doi:10.1136/bmj.m689 .
[23] BELLE V, PAPANTONIS I. Principles and practice of explainable machine learning[J]. Front Big Data, 2021, 4: 688969. doi:10.3389/fdata.2021.688969 .
[24] DELPINO F M, COSTA ? K, FARIAS S R, et al. Machine learning for predicting chronic diseases: A systematic review[J]. Public Health, 2022, 205: 14-25. doi:10.1016/j.puhe.2022.01.007 .
Outlines

/